Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W L Lam

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Journal of Crohn'S & Colitis|February 16, 2019
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab CohortN Plevris, C S Chuah, R M Allen, et al.
Oncogene|October 8, 2013
EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer riskI M Wilson, E A Vucic, K S S Enfield, et al.
Science (New York, N.Y.)|October 28, 2021
WTO must ban harmful fisheries subsidiesU Rashid Sumaila, Daniel J Skerritt, Anna Schuhbauer, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Journal of Crohn'S & Colitis|February 16, 2019
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab CohortN Plevris, C S Chuah, R M Allen, et al.
Oncogene|October 8, 2013
EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer riskI M Wilson, E A Vucic, K S S Enfield, et al.
Science (New York, N.Y.)|October 28, 2021
WTO must ban harmful fisheries subsidiesU Rashid Sumaila, Daniel J Skerritt, Anna Schuhbauer, et al.
Pageof 8